Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 112, Issue 6, 2004, Pages 1029-1035

  Nakashima, Kazue ^a   Shimada, Hideaki ^a   Ochiai, Takenori ^a   Kuboshima, Mari ^a   Kuroiwa, Namiko ^a   Okazumi, Shinichi ^a   Matsubara, Hisahiro ^a   Nomura, Fumio ^a   Takiguchi, Masaki ^a   Hiwasa, Takaki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Esophageal carcinoma; SEREX; Squamous cell carcinoma; TROP2; Tumor marker

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN; PROTEIN TROP2; RECOMBINANT DNA; TROP2 ANTIBODY; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL IMMORTALIZATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEROLOGY; TUMOR VOLUME; WESTERN BLOTTING;

AGED; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 8644232738     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20517     Document Type: Article

References (30)

1. Shimada H, Hoshino T, Okazumi S, Matsubara H, Funami Y, Nabeya Y, Hayashi H, Takeda A, Shiratori T, Uno T, Ito H, Ochiai T. Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell cancer. Br J Cancer 2002;86:552-7.
2. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H. Ochiai T. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 2003;133:486-94.
3. Daly JM, Karnell LH, Menck HR. National cancer data base report on esophageal carcinoma. Cancer 1996;78:1820-8.
4. Kim YH, Ajani JA, Ota DM, Lynch P, Roth JA. Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach. Cancer 1995;75:451-6.
5. Munck-Wikland E, Kuylenstierna R, Wahren B, Lindholm J, Haglund S. Tumor markers carcinoembryonic antigen, CA 50, and CA 19-9 and squamous cell carcinoma of the esophagus. Pretreatment screening. Cancer 1988;62:2281-6.
6. McKnight A, Mannell A, Shperling I. The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer. Br J Cancer 1989;60:249-51.
7. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Miyazawa Y, Shiratori T, Hayashi H, Gunji Y, Ochiai T. Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma. J Am Coll Surg 2003;196:573-8.
8. Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, Kobayashi S, Ochiai T. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer 2000;89:1677-83.
9. Nakao M, Shichijo S, Imaizumi T, Inoue Y, Matsunaga K, Yamada A, Kikuchi M, Tsuda N, Ohta K, Takamori S, Yamana H, Fujita H, et al. Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J Immunol 2000;164:2565-74.
10. Toh U, Yamana H, Nakao M, Imai Y, Seki N, Takasu H, Kaneshige T, Fujita H, Shirouzu K, Itoh K. HLA class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers. Cell Immunol 1997;177:137-43.
11. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995;92:11810-3.
12. Chen YT, Boyer AD, Viars CS, Tsang S, Old LJ, Arden KC. Genomic cloning and localization of CTAG, a gene encoding an auto immunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. Cytogenet Cell Genet 1997;79:237-40.
13. Jäger E, Chen Y-T, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998;187:265-70.
14. Takahashi K, Kanazawa H, Chan H, Hosono T, Takahara M, Sato K. A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T.T. T.Tn.). Jpn J Oral Maxilofac Surg 1990;36:307-16.
15. Shimada H, Shimizu T, Ochiai T, Liu T-L., Sashiyama H, Nakamura A, Matsubara H, Gunji Y, Kobayashi S, Tagawa M, Sakiyama S, Hiwasa T. Preclinical study of adenoviral p53 gene therapy for esophageal cancer. Surg Today 2001;31:597-604.
16. Nishihira T, Kasai M, Mon S, Watanabe T, Kuriya Y, Suda M, Kitamura M, Hirayama K, Akaishi T, Sakai T. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of esophagus. Cancer Sci 1979;70:575-84.
17. Oka M, Hirose K, Iizuka N, Aoyagi K, Yamamoto K, Abe T, Hazama S, Suzuki T. Cytokine mRNA expression patterns in human esophageal cancer cell lines. J. Interferon Cytokine Res 1995;15:1005-9.
18. Sashiyama H, Shino Y, Kawamata Y, Tomita Y, Ogawa N, Shimada H, Kobayashi S, Asano T, Ochiai T, Shirasawa H. Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16. Int J Oncol 2001;19:97-103.
19. Sobin LH, Wittekind CH. UICC TNM Classification of malignant tumors. 5th ed. New York: John Wiley & Sons, Inc., 1997.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
21. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970;227:680-5.
22. Hsu SM, Raine L. Fanger AH. A comparative study of the peroxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay anti-body. Am J Clin Pathol 1981;75:734-8.
23. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, Capri MG Alberti S. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 1995;62:610-8.
24. Yoshida S, Kumano Y, Yoshida A, Numa S, Yabe N, Hisatomi T, Nishida T, Ishibashi T, Matsui T. Two brothers with gelatinous drop-like dystrophy at different stages of the disease: role of mutational analysis. Am J Ophthalmol 2002;133:830-2.
25. Ren Z, Lin PY, Klintworth GK, Iwata F, Munier FL, Schorderet DF, El Matri L, Theendakara V, Basti S, Reddy M, Hejtmancik JF. Allelic and locus heterogeneity in autosomal recessive gelatinous drop-like corneal dystrophy. Hum Genet 2002;110:568-77.
26. Ross AH, Herlyn D, Iliopoulos D, Koprowski H. Isolation and characterization of a carcinoma-associated antigen. Biochem Biophys Res Commun 1986;26:297-303.
27. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998;95:5211-6.
28. Herlyn D, Herlyn M, Ross AH, Ernst C, Atkinson B, Koprowski H. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods 1984;12:157-67.
29. Terrinoni A, Dell'Arciprete R, Fornaro M, Stella M, Alberti S. Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells. Genes Chromosomes Cancer 2001;31:209-20.
30. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Shiratori T, Hayashi H, Takeda A, Ochiai T. Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. Surgery 2002;132:41-7.